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Drug overdose deaths have become an escalating epidemic in the U.S. and surpassed 
motor vehicle collisions as the leading cause of accidental death. To combat opioid overdose, 
naloxone distribution to the public has been initiated in some states as a harm reduction strategy. 
Naloxone has been used for many years among hospital professionals as a life-saving antidote to 
reverse the respiratory depression effects of opioids, and the FDA has approved take-home 
naloxone devices for layperson use. Though legislation has been introduced in many states, such 
as Tennessee, to allow provider prescription of naloxone to laypersons, minimal data have been 
recorded to determine if NPs are willing to prescribe naloxone to patients.  
Purpose 
The purpose of this project was to explore how knowledge, attitudes, and subjective 
norms influence intentions to prescribe naloxone to laypersons among Tennessee nurse 
practitioners (NPs) following implementation of state naloxone distribution laws.  
Methods 
Using the Theory of Reasoned Action as the theoretical framework, NPs’ knowledge, 
attitudes, subjective norms, and intentions to prescribe naloxone were assessed using web-based 
surveys. While 6,196 Tennessee NPs were emailed the survey, purposive sampling included only 
NPs practicing in adult primary care clinics, family practice clinics, pain management clinics, 
and emergency departments in the final sample. Descriptive and Pearson’s Chi-Square statistics 
were used to analyze survey responses and correlations were established using SPSS software.  
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Of 343 NPs included in the final sample, only 16.6% intended to prescribe naloxone to 
laypersons, which significantly correlated with NPs’ knowledge, attitudes, and subjective norms. 
No significant correlation was found between geographical location and intention to prescribe. 
Intention to prescribe percentages increased dramatically from 16.6% to 58% when NPs were 
asked if they would prescribe naloxone to laypersons with prescribing protocols in place.  
Discussion 
This study’s results confirmed the literature’s suggestion that healthcare providers are 
relatively unaware of the evidence surrounding naloxone distribution safety and efficacy. 
Negative attitudes toward naloxone distribution and uncertainty over legal protection contributed 
to unwillingness to prescribe. Better education, training, legal clarification, and prescribing 
protocols should be given to NPs and other healthcare providers to increase involvement with 
naloxone prescription for laypersons. 
Keywords:​ naloxone, naloxone distribution, opioid overdose, opioid overdose deaths, 
provider attitudes, nurse practitioner attitudes, harm reduction strategy, public health, theoretical 















Public Access to Naloxone: Intention to Prescribe Among Tennessee Nurse Practitioners 
Across the globe, drug overdose has become a devastating epidemic and surpassed motor 
vehicle collisions as the leading cause of adult accidental death in the United States (U.S.) 
(Centers for Disease Control and Prevention [CDC], 2015a). Of the annual U.S. death toll, 
pharmaceuticals contributed to approximately 22,767 overdose deaths with 71.3% related to 
opioid pain medications (CDC, 2015a). For many years, the life-saving opioid antidote, known 
as naloxone, has been used among healthcare professionals in hospitals to quickly and effectively 
reverse the respiratory depressive effects of opioids (Wermeling, 2015). Public health efforts and 
current legislation have focused on distributing naloxone to non-medically trained laypersons 
and training these laypersons to administer naloxone to victims in opioid overdose events. This 
Doctor of Nursing Practice (DNP) project explored the psychosocial factors influencing nurse 
practitioners’ (NPs’) intentions to prescribe naloxone to laypersons as an opioid overdose 
prevention strategy. 
Background 
Opioid Overdose Epidemic and Naloxone Distribution 
The number of opioid overdose deaths has continued to rise each year causing a public 
health crisis as well as almost $72 billion in annual medical costs (U.S. Department of Health 
and Human Services [HHS], 2013). While intravenous (IV) heroin caused many deaths, 
prescription opioid pain medications, such as oxycodone, hydrocodone, and morphine, have 
killed more people than cocaine and heroin combined (National Institute on Drug Abuse, 2014). 
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This complex problem has been directly associated with inappropriate prescription of opioid 
medications by healthcare providers, who wrote nearly 259 million opioid prescriptions in one 
year (CDC, 2016). While some patients have truly required prescription opioids for chronic pain 
management, other individuals have solicited providers to prescribe opioids for personal 
illegitimate use, selling on the street, or supplying to friends and family. 
To reduce the high number of opioid overdose deaths that occurred while victims waited 
for help to arrive, naloxone distribution was introduced as a harm reduction strategy, equipping 
individuals most likely to encounter opioid overdose events with the life-saving antidote (Davis, 
2015). Efforts to increase public access to naloxone supplement ongoing opioid overdose 
prevention efforts, such as prescription drug monitoring databases, prescription drug disposal 
programs, substance abuse rehabilitation, and stricter opioid prescribing guidelines for healthcare 
providers (Kim, Irwin, & Khoshnood, 2009). Forty-three states have implemented legislation 
allowing provider prescription of take-home naloxone (THN) to non-medically trained 
laypersons, which include patients and their family members or friends (Davis, 2015). 
Thirty-five of these 43 states also passed Good Samaritan laws to protect laypersons and 
naloxone prescribers from legal repercussions when laypersons administer naloxone to opioid 
overdose victims in pre-hospital emergencies (Davis, 2015). Not only has public naloxone 
distribution become an overdose prevention strategy in the U.S., but also the World Health 
Organization (2014) endorsed its global significance of successfully preventing overdose deaths 
in countries around the world, such as England, Australia, Canada, and Scotland.  
Many of the U.S. naloxone laws were introduced in response to the 2014 U.S. Food and 
Drug Administration (FDA, 2014) approval of Evzio™, which was the first THN auto-injector 
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device intended for layperson administration in pre-hospital settings. More recently in November 
2015, the FDA (2015) announced its approval of a naloxone intranasal (IN) spray, which 
expanded public access to THN by approving an alternative delivery route. Though 
community-based overdose education programs (OEPs) have been providing generic THN kits 
and overdose response training to opioid abusers since 1996, the recent increase in state 
naloxone laws and growing political support for public naloxone access have dramatically 
expanded THN distribution to diverse settings and patient populations (Wheeler, Jones, Gilbert, 
& Davidson, 2015). As of 2014, THN was used to reverse approximately 26,463 opioid 
overdoses among individuals receiving overdose response training at community OEPs across 
the U.S., and research has supported that laypersons who receive appropriate training can 
accurately recognize signs of overdose and safely administer naloxone (Wheeler et al., 2015). 
Evidence suggests that improving public access to naloxone is not only effective and practical, 
but it is also cost-effective (Coffin & Sullivan, 2013).  
Healthcare Provider Involvement with Naloxone Distribution 
Despite increased legislation and political support for naloxone distribution across the 
U.S., poor provider involvement with naloxone distribution efforts has been recognized as a 
significant barrier to realizing the widespread impact of THN on opioid overdose (Beletsky et al., 
2007; Burris et al., 2009; Davis, 2015; Kim et al., 2009). In a study by Beletsky et al. (2007), 
only 23% of surveyed physicians reported knowledge of naloxone prescription to laypersons as 
an overdose prevention strategy. Fifty-four percent of the same sample stated that they would not 
prescribe THN, which authors attributed to lack of awareness regarding naloxone laws, negative 
attitudes toward drug users, and malpractice liability concerns (Beletsky et al., 2007). If 
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healthcare providers remain unwilling to prescribe naloxone to laypersons, this harm reduction 
strategy’s true effectiveness on decreasing overdose deaths will be impossible to realize. 
Tennessee’s Opioid Crisis and Naloxone Distribution Status 
In 2014, 1,263 Tennesseans died of opioid overdose, a death toll that has continued to 
rise each year despite the Tennessee Department of Health’s (TDH’s, 2015b) efforts to decrease 
substance abuse and misuse. Because Tennessee was ranked as the highest prescribing state for 
opioid analgesics with 143 prescriptions written per 100 persons, it has become crucial to glean 
more information about Tennessee provider prescribing practices (CDC, 2016). As of March 19, 
2016, 295 chronic pain management clinics were registered with TDH (2016), which alludes to 
the excessive number of opioids in circulation. To counteract this problem, the TDH (2014) 
introduced chronic pain management guidelines that describe new opioid prescribing protocols, 
the controlled substance monitoring database, prescription drug disposal, and naloxone 
distribution to laypersons.  
In April 2014, Tennessee policymakers passed the Naloxone Rescue Act, which allows 
healthcare providers to prescribe naloxone to laypersons and protects all involved parties against 
civil prosecution if acting in good faith (Naloxone Rescue Act, Tenn. Code Ann. § 63-1-152 
(2014)). The Addiction Treatment Act added necessary adjustments to the Good Samaritan law 
to allow better protection from criminal prosecution for laypersons who call emergency services 
after administering naloxone in an overdose event (Addiction Treatment Act of 2015, Tenn. 
Code Ann. § 63-1-1 ​et seq.​ (2015)). Since the conception of this DNP project, legislation and 
implementation of THN distribution in Tennessee and other U.S. states have evolved at a fast 
pace. On September 23, 2015, CVS Pharmacy (2015) announced that its stores in 12 states, 
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which includes Tennessee, will sell THN to patients without individual prescriptions. Following 
CVS Pharmacy’s example, Walgreens Pharmacy (2016) made a February 9, 2016, 
announcement that its stores will also begin dispensing THN without prescriptions in 35 states 
and Washington, D. C. This type of THN distribution would be in line with Tennessee’s 
Naloxone Rescue Act through its use of a standing order agreement between a physician and 
CVS Pharmacy (2015). Little to no data have been published to evaluate if naloxone laws have 
reduced the number of opioid overdose deaths in Tennessee. 
Purpose of Project 
More data have been needed to discover whether or not NPs are aware of naloxone laws 
and if they believe naloxone distribution is a good strategy for opioid overdose prevention. 
Though Tennessee’s Naloxone Rescue Act has been in effect for almost two years, no data have 
been found to determine if NPs intend to prescribe THN to patients and their friends or family 
members. The purpose of this project is to explore the knowledge, attitudes, subjective norms 
and prescribing intentions among Tennessee NPs in response to the Naloxone Rescue Act. The 
investigator will attempt to answer the following three project questions: 1) Does lack of 
knowledge of naloxone distribution laws correlate with NPs’ intentions to prescribe naloxone to 
laypersons? 2) Do underlying attitudes or subjective norms correlate with NPs’ intentions to 
prescribe naloxone to laypersons? 3) Do correlations exist between NPs practicing in certain 
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To better capture the philosophical underpinnings of this project, a theoretical framework 
was used throughout its design. Social psychologists Ajzen and Fishbein (1980) first developed 
philosophies on the relationship between an individual’s attitudes and his or her behavior. Their 
book introduced the theory of reasoned action (TRA) into a broad range of professions and 
explained the association between attitudes, beliefs, intentions, and behavior (Kuhns & McEwen, 
2011). The TRA’s goal was to better understand a variety of positive and negative behaviors and 
to predict individuals’ choices to perform these behaviors (Glanz, Burke, & Rimer, 2015).  
The following concepts were explored in the TRA conceptual model: behavioral beliefs, 
evaluations of behavioral outcomes, attitude toward behavior, normative beliefs, motivation to 
comply, subjective norm, behavioral intention and behavior (Ajzen & Fishbein, 1980). 
According to the TRA’s definitions, behavioral belief involved the view that certain attributes 
are associated with behavioral performance (Evans, Ndetan, & Williams, 2009). The evaluation 
of behavioral outcomes could be of positive or negative value, and the attitude toward behavior 
referred to the individual’s overall acceptability of the performed behavior (Kuhns & McEwen, 
2011). Normative beliefs, also known as subjective norms, reflected the social pressure on an 
individual to engage or disengage in a particular behavior (Kuhns & McEwen, 2011). Similar to 
normative beliefs, motivation to comply involved the subjective motivation of an individual to 
act according to the expectation of others (Evans et al., 2009). Glanz et al. (2015) stated that 
behavior intention, which is the individual’s perceived probability to perform the behavior, is the 
most significant predictor of behavior.  
According to Kuhns and McEwen (2011), the TRA made the assumption that people are 
capable of making rational decisions based on what information they have received. Therefore, it 
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may also be assumed that the TRA interprets voluntary behavior rather than involuntary action. 
In addition, the TRA assumed that intention is the primary determinant of individuals’ behaviors, 
and the other factors may be weighted differently from person to person (Glanz et al., 2015). 
Glanz et al. (2015) described how the TRA conceptual relationships create a formula for 
self-efficacy and a catalyst for behavior change potential.  
Application of a Modified Theory of Reasoned Action  
With its psychosocial roots, the TRA was a natural fit for a project examining attitudes 
and beliefs of NPs and their intentions to prescribe naloxone for layperson use in Tennessee. 
Some NPs may have underlying normative beliefs regarding opioid abusers or overdose events, 
which may influence their intentions to prescribe naloxone. Their innate attitudes about naloxone 
access to the public may also weigh their decisions to prescribe in certain practice settings. They 
may fear liability or legal repercussions if they prescribe naloxone. In some clinics, providers 
may feel a need to conform to behaviors based on other providers’ support or opposition to the 
new laws.  
Though the TRA will provide useful insight into the underlying attitudes, beliefs, and 
intentions of NPs, the investigator also identified knowledge as a likely influencing factor for 
behavior change. Because Tennessee’s Naloxone Rescue Act has only recently been introduced 
to providers, many NPs may lack knowledge of its existence or the availability of naloxone for 
public use. This lack of awareness may directly correlate with their prescribing beliefs, 
evaluations of prescribing outcomes, and attitudes toward prescribing naloxone. Knowledge was 
not directly explored as a variable in the TRA, but Bandura’s (1994) social cognitive learning 
theory linked knowledge with self-efficacy as a strong indicator that a person will feel confident 
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enough to perform specific tasks. Stanley and Pollard (2013) combined knowledge and 
self-efficacy with underlying attitudes in their study examining nurse management of pediatric 
pain. After considering the purpose of this scholarly project, the TRA combined with the 
knowledge variable of the social cognitive learning theory provided the most comprehensive 
approach to determining the factors influencing provider intention to prescribe. Figure 1 provides 
a conceptual model for the modified TRA. 
Methods 
Participants 
In Tennessee, advanced practice registered nurses (APRNs) made up 35 of the top 50 
opioid prescribers (Tennessee Nurses Association, 2014). Therefore, NPs were chosen as a 
representative provider sample who regularly treat and prescribe to patients at-risk for opioid 
overdose. A public record list of 10,910 Tennessee APRNs was obtained on March 27, 2015, via 
the TDH’s (2015a) health professional licensing public report database. Using purposive 
sampling, this list was screened to remove duplicates and APRNs with no listed email address. 
After excluding all APRNs other than NPs, 6,196 NPs (​N​= 6,196) were solicited to be potential 
study participants. The following inclusion criteria were applied to NP survey responses in order 
to retain the final sample: must prescribe opioids to patients in practice, must practice in 
Tennessee, must work in primary care clinic, family practice, pain management practice, or 
emergency department (ED). Nurse practitioners receiving the survey were also required to have 
a working email and internet connection to access the survey’s uniform resource locator (URL).  
Materials  
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Data collection tool. ​The Take-Home Naloxone Prescriber survey (THNPS) was used to 
gather data for this project. The investigator used the modified TRA as a theoretical framework 
to develop survey questions. Though a standardized data collection tool was desired, the 
investigator was unable to identify one that met the needs of this study. In addition, a study by 
Darker and French (2009) demonstrated that study participants could not adequately comprehend 
overly standardized theory-based questionnaires or lengthy surveys. With this in mind, the 
investigator was able to use necessary flexibility with the modified TRA survey. This flexibility 
helped the investigator explore the pertinent constructs and cater the survey to the selected 
audience.  
Designed for healthcare providers with a masters-level degree, the THNPS asked 15 
close-ended questions to reflect to the main concepts of the modified TRA: ​knowledge​, ​attitudes​, 
subjective norms​, and ​intentions​. Underneath each of these headings, specific questions were 
asked that addressed the concept in relation to NP prescribing practices. All THNPS questions 
were quantitative in nature with one qualitative free-text section included at the end of the survey 
for participants to include additional comments as needed. Questions were formatted in the 
English language, and the following terms were defined: ​prescription opioids​, ​heroin,​ ​take-home 
naloxone​, ​laypersons​, and ​protocols​.  Five demographic (gender, race/ethnicity), geographic 
(urban versus rural counties), and practice-specific (years of working experience, current 
employment specialty) questions were included to further screen participants and establish 
variable relationships. Though the THNPS has not gone through standard methods for validation, 
the data collection tool was externally reviewed and approved by three experts for content 
validity (Huck, 2012b). The THNPS was also tested among a sample group of 21 individuals to 
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determine internal consistency. The THNPS survey instrument is displayed in Table 1 and 
demographic items are located in Table 2.  
Apparatus. ​Qualtrics web-based survey software was used to design and distribute the 
THNPS via email. A Microsoft Excel list of 6,196 NPs was imported into Qualtrics with first 
name, last name, and email address. The investigator programmed survey software to allow 
participation by invitation only and prevent participants from completing more than one survey. 
The software was also programmed to distribute emails to participants and to anonymize 
participants’ responses, which alphanumerically coded responses and removed identifying 
information. Responses were programmed to be saved but not recorded until participants 
submitted their completed surveys. Prior to being exported for statistical analyses, responses 
were stored as raw data in Qualtrics’ secured, on-line database. Per the software’s security 
statement, all data collected, transferred, or stored via the Qualtrics (2015) survey were protected 
by high-end firewall systems. Transport Layer Security (TLS) encryption and password 
protection were used to store data according to Health Information Technology for Economic 
and Clinical Health Act (HITECH) requirements (Qualtrics, 2015). Only the investigator had 
access to the password and collected data. The Statistical Package for the Social Sciences (SPSS) 
software was used for statistical analyses. 
Monetary incentive. ​A $150 Visa pre-paid gift card was promoted as a monetary 
incentive in the survey invitation email to boost response rates. Although all responses were 
anonymized and coded, the investigator was able to use Qualtrics software to randomly select the 
$150 Visa pre-paid gift card winner upon survey completion. The original NP sample was linked 
to the THNPS for scheduled email distribution. Using Qualtrics’ programmable filters, the 
16 
PUBLIC ACCESS TO NALOXONE 
 
investigator extracted qualified participants into a separate sample by tracking THNPS email 
distribution and survey completion history. Therefore, 977 NPs who completed the survey were 
identified without linking participants to their responses. Using Qualtrics’ randomization feature, 
this sample was randomized 20 times prior to selecting the 57​th​ name on the list as the winner. 
The number 57 was chosen using the Random Number Generator (2015) site. The winner was 
sent a congratulatory email through the Qualtrics website and asked to confirm his or her mailing 
address. The winner received the Visa gift card via U.S. Postal Service.  
Design 
A descriptive and correlational design was used for this project. To achieve the project’s 
purpose, the investigator sought to explain relationships among the independent and dependent 
variables. Intention to prescribe was established as the dependent variable. Knowledge, attitudes, 
subjective norms, and geographic location were deemed independent variables.  
Procedures 
Data collection. ​Data collection took place from October 7, 2015 to November 7, 2015. 
Survey invitation emails with the project explanation and THNPS URL were scheduled for 
distribution at 0700 on October 7​th​. Invitation emails explicitly stated that participation was 
voluntary and clicking on the survey URL implied consent to the study. Reminder emails were 
scheduled at weekly intervals and were sent only to NPs who had not completed the survey. In 
order to boost response rates, emails advertised a $150 Visa pre-paid gift card to one randomly 
selected participant who completed the survey. On average, participants completed the survey in 
approximately seven minutes, and completed survey responses were automatically recorded 
upon submission. When participants submitted their surveys, they received a thank you email, 
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which further described Tennessee’ Naloxone Rescue Act and provided a link to the TDH 
naloxone information site. Invitation and reminder emails included an option to opt out of the 
study, and clicking on the “unsubscribe” link removed participants from the email list and 
sample. The investigator’s contact details were also provided in each email, so participants could 
ask questions or voice concerns.  
Statistical analyses. ​Survey responses were exported as raw data from the Qualtrics 
database into SPSS for statistical analyses. Questions and responses were coded 
alphanumerically and analyzed in SPSS. Intention to prescribe was deemed the dependent 
variable, and all other question responses were considered independent variables. Descriptive 
statistics were used to determine participants’ demographic characteristics, and demographic 
characteristics were correlated with intention to prescribe using Pearson’s Chi-Square statistical 
tests. Chi-Square statistical tests were also used to determine correlations among participants’ 
responses regarding knowledge, attitudes, subjective norms, with intention to prescribe THN. To 
avoid cell sizes too small to appropriately perform Chi-Square testing, the Likert scale responses 
found in Table 1 of ​agree, strongly agree,​ and ​disagree, strongly disagree​, were combined and 
recoded to ​agree​ and ​disagree​ as seen in Table 3. For the same reason, responses for question 2 
in Table 1 were combined and recoded to ​very aware, somewhat aware, ​and ​not aware​. 
Statistical significance was established at alpha level 0.05. When Chi-Square tests generated 
statistically significant results (i.e. ​p​<0.05), post hoc procedures were used to identify more 
specific correlations and better answer research questions as suggested by Huck (2012a) and 
Sheskin (2004). While several acceptable approaches have been used for post hoc testing of 
Chi-Square results, the investigator employed the standardized residual method for post hoc 
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testing in this study (​Garcia-Perez & Nunez-Anton, 2003; Sheskin, 2004; Beasley & 
Schumacker, 1995; how2stats, 2014)​.  
Ethics statement. ​This project was approved by the Institutional Review Board of 
Belmont University in Nashville, Tennessee.  
Results 
Sample Characteristics 
Out of 6,196 NPs (​N​=6,196) solicited, 2,652 NPs opened the invitation email, and 1,149 
started the survey. Of the participants who started the survey, 977 completed the entire survey, 
which elicited a response rate of 15.8%. After applying inclusion criteria to completed responses, 
343 NPs (​n​=343) were kept as the final participant sample. Because most of the final sample 
were white (​n​=312 [91%]) and female (​n​=310 [90.4%]), demographic data were compared with 
all Tennessee APRN demographic statistics to determine if this homogeneity was proportionally 
similar to statewide APRN demographics. This comparison showed that overall Tennessee 
APRN demographics also reflect 90.2% female and 81% white characteristics, which 
demonstrates that the study’s sample is representative of Tennessee’s APRN population 
(Tennessee Action Coalition, n. d.). Many NPs reported between 1 to 6 years of experience 
(​n​=154 [44.9%]), employment in family practice site (​n​=170 [49.6%]), and practice locations in 
urban areas (​n​=172 [50.1%]). See Table 2 for further details on sample characteristics.  
Sample characteristics and intention to prescribe. ​When correlating the samples’ 
characteristics with intention to prescribe, practice site was the only variable that significantly 
correlated with intention to prescribe (​p​=0.000). According to post hoc tests, a strong, significant 
correlation was found between NPs practicing in pain management clinics and intention to 
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prescribe naloxone (​p​<0.001). In contrast, NPs practicing at family practice sites reported no 
intention to prescribe naloxone, which was statistically significant at ​p​<0.05. No significant 
correlation was found between intention to prescribe and gender, race/ethnicity, years of 
experience, and urban or rural location. See Table 2 for the samples’ statistical characteristics in 
correlation with intention to prescribe.   
Intention to Prescribe Naloxone  
From the sample of 343 NPs, only 16.6% (​n​=57) reported that they intend to prescribe 
naloxone to laypersons. Of particular interest, this percentage increased to 58% (​n​=199) when 
NPs were asked about their intentions to prescribe naloxone if protocols and prescribing 
guidelines were in place. Overall, NPs predominantly reported being unsure (​n​=166 [48.4%]) 
about whether or not they intend to prescribe naloxone. Table 3 shows more details on NPs 
responses regarding intention to prescribe. When instructed to select all that apply, most NPs 
reported comfort in prescribing naloxone to the following individuals: patients taking moderate 
to high doses of oral opioids for pain management (​n​=183), law enforcement personnel (​n​=167), 
known or suspected oral opioid addicts (​n​=136), and family members or friends of patients 
taking oral opioids for pain management (​n​=124). Figure 1 displays more information on to 
whom NPs intend to prescribe naloxone.  
Knowledge and intention to prescribe. ​Each of the three questions measuring NP 
knowledge of THN and their relationships to NP intention to prescribe THN indicated strong 
statistical significance (​p​=0.000). When asked about their knowledge of THN distribution 
initiatives in the U.S., 46.1% (​n​=158) of NPs reported that they were very aware. Of the NPs 
who were very aware of THN distribution, most (44.3% [​n​=70]) were unsure if they would 
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prescribe naloxone. A significant correlation was seen between NPs who were not aware of THN 
distribution and who did not intend to prescribe THN (​p​<0.001). In regard to knowledge about 
Tennessee’s THN laws, 62.1% (​n​=213) of NPs said they were unsure, 19% (​n​=65) said they 
were aware, and 19% (​n​=65) said they were unaware of these laws. Those who were aware of 
Tennessee’s THN laws were also more likely to prescribe naloxone (​p​<0.001). Furthermore, NPs 
who were unaware of Tennessee’s laws reported that they do not intend to prescribe naloxone 
(​p​<0.01). Only 5% (​n​=17) of the sample had previously prescribed THN in their practice, and 
the remaining 95% (​n​=326) reported no experience prescribing THN. In a strong correlation, the 
NPs who previously prescribed THN were significantly more likely to prescribe THN in the 
future (​n​=16 [94.1%], ​p​<0.001). There were also significant correlations between those who had 
never prescribed THN and NPs who do not intend to prescribe (​p​<0.01) and those who were 
unsure if they would prescribe (​p​<0.001). See Table 3 for further details on how NP knowledge 
correlated with intention to prescribe naloxone. 
Attitudes and intention to prescribe. ​When measuring each of the four questions 
correlating NP attitudes about THN and intention to prescribe THN, strong statistical 
significance was found (​p​=0.000). Forty-eight percent (​n​= 166) of NPs felt that THN is a good 
strategy for opioid prevention, but they predominantly remained unsure regarding intention to 
prescribe THN (​p​<0.01). Nurse practitioners who disagreed that THN is a good strategy were 
significantly opposed to prescribing THN (​p​<0.001). Seventy percent (​n​= 240) of NPs agreed 
that laypersons can safely and effectively administer THN in overdose events; however, these 
NPs mostly reported being unsure whether or not they intend to prescribe THN (​p​<0.001). Those 
who disagreed with the safety and effectiveness of layperson administration were significantly 
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less likely to prescribe THN (​p​<0.001). In regard to legal implications, most NPs (​n​=157 
[45.8%] and ​n​=157 [45.8%]) neither agreed nor disagreed that they felt protected by criminal or 
civil prosecution if they prescribed THN to laypersons. A very small portion of NPs (​n​=66 
[19.2%] and ​n​=54 [15.7%]) did feel protected from criminal and civil prosecution, which 
correlated significantly with intention to prescribe THN (​p​<0.001 and ​p​<0.001). Additional 
statistical correlations between attitudes and intention to prescribe may be found in Table 3.  
Subjective norms and intention to prescribe. ​Three out of the four questions covering 
subjective norms significantly correlated with intention to prescribe. Most NPs (​n​=152 [44.3%]) 
reported that their health provider peers were unaware of THN laws, which significantly 
correlated with deciding not to prescribe THN (​p​<0.05). When asked if their health provider 
peers supported THN prescription, NPs predominantly responded neither agree nor disagree 
(​n​=202 [58.95]), which directly related with being unsure of intention to prescribe (​p​<0.001). 
Even though most NPs were ambivalent, those who felt their provider peers supported THN 
were more likely to prescribe THN themselves (​p​<0.001), and those who felt their provider peers 
opposed THN were less likely to prescribe THN themselves (​p​<0.001). Regardless, NPs reported 
that peer pressure was not an influencing subjective norm (​n​=244 [71.1%]) and was not 
significantly related to intention to prescribe (​p​=0.447). Most NPs (​n=​184 [53.6%]) disagreed 
that personal reasons would influence their decision to prescribe THN, which significantly 
correlated with their report that they do not intend to prescribe THN to laypersons (​p​<0.01). 









Geographic Location and Clinical Sites 
At the beginning of this project, the investigator sought to establish if geographic location 
(i.e. rural, urban, combined rural/urban) impacted NPs’ intentions to prescribe THN. It was 
important to examine geographic implications as the literature suggests opioid overdose deaths 
are more prevalent in rural areas (CDC, 2015b; Rosenblatt, Andrilla, Catlin, & Larson, 2015). 
Also, evidence has yet to conclude whether or not prescribers’ attitudes and intentions to 
distribute THN vary depending on if they practice in rural or urban locations. According to this 
project’s findings, significant correlations were not found between NPs who practiced in rural, 
urban, or combined areas and intention to prescribe. These findings suggest that geographical 
locations do not seem to encourage nor deter NPs’ decisions to prescribe THN to laypersons. For 
future rural opioid prevention outreach, Tennessee advocates may consider following the Project 
Lazarus model, an OEP and naloxone distribution program that has dramatically decreased 
overdose deaths in rural North Carolina (Albert et al., 2011).  
 While geographical locations of NPs were insignificant to their prescribing intentions, 
the types of NP clinical practice sites were strongly significant. In particular, NPs practicing in 
pain management clinics were significantly more likely to prescribe THN to laypersons. This 
finding is important because NPs practicing in pain management clinics will have the greatest 
access to patients taking large amounts of opioid pain medication who may be at risk for 
overdose. Not only would these NPs have the opportunity to prescribe THN to patients along 
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with their opioids, but they could also contribute valuable data regarding appropriate THN 
candidate selection and actual THN use among oral opioid users. In contrast to pain management 
NPs, family practice NPs were found to be significantly less likely to prescribe THN. Providing 
insight into this finding, one study participant commented at the end of the survey, “I am wary of 
prescribing narcotic pain medications in my practice, and I would refer patients needing 
long-term treatment to pain management. They could then decide to prescribe naloxone.” The 
sentiment that NPs would feel more comfortable deferring THN prescriptions to pain 
management specialists was echoed in the literature and throughout the final comments section 
by other family, adult primary care, and ED NPs (Matheson et al., 2014). In contrast, Leece, 
Orkin, Shahin, and Steele (2015) and Klimas, Egan, Tobin, Coleman, and Bury (2015) found that 
family practice providers in Canada and Ireland were not opposed to providing THN prescription 
and overdose education in the primary care setting, and they did not suggest that specialist 
involvement be required. It was interesting that only 7.5% of ED NPs in this study endorsed 
intention to prescribe THN, since EDs have become a successful target location for naloxone 
distribution efforts in other states (Dwyer et al., 2015; Samuels, 2014). The theory has been that 
ED providers encounter the highest risk patients (i.e. individuals brought to the ED for opioid 
overdose) and would be able to give them THN to prevent future overdose events (Dwyer et al., 
2015). This project’s findings suggested that ED naloxone distribution is not likely occurring in 
Tennessee.  
Knowledge 
Over the last decade, THN distribution has been a popular topic among U.S. 
policymakers, physicians, and public health professionals. With the recent increase in media 
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coverage of the THN movement and expansion of legal accessibility to THN, it is not surprising 
that many participants were aware of THN distribution across the U.S. as an opioid overdose 
death prevention strategy. Despite being aware of the overall THN movement, only 19% of NPs 
reported awareness of Tennessee’s law allowing THN prescription to laypersons. Of interest, 
NPs with little to no knowledge of THN distribution in the U.S. or Tennessee were significantly 
less likely to prescribe THN to laypersons, an association also found in other research studies 
(Beletsky et al., 2007; Green et al., 2013). Sixteen of the seventeen NPs (94.1%) who had 
previous experience prescribing THN to laypersons responded “yes” when asked if they intend 
to prescribe THN to laypersons in the future, which demonstrates how adequate knowledge 
positively influences intention to prescribe. These correlational findings between knowledge and 
intention to prescribe make sense, as NPs are educated to prescribe medications of which they 
have a sufficient understanding and familiarity.  
Demonstrating the disconnect between general awareness and prescriptive competency, 
Wilson, Spicyn, Matson, Alvanzo, and Feldman (2016) found that 80% of internal medicine 
residents were aware of THN use with 90% reportedly willing to prescribe THN to laypersons, 
yet only 15% applied the knowledge by prescribing THN to at-risk patients. Researchers and 
policymakers are calling for improved provider-focused education so that prescribers are aware 
of THN’s evidence-based safety and efficacy, know how to appropriately prescribe THN, and 
understand the legal implications of prescribing THN to laypersons (Beletsky et al., 2007; Green 
et al., 2013; Kim et al., 2009; Klimas et al., 2015; Leece et al., 2015; Wilson et al., 2016).  
Attitudes  
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Along with knowledge, this project established a significant correlation between NP 
attitudes toward prescribing THN and willingness to prescribe THN to patients and their families 
or friends. While NP responses portrayed predominantly positive attitudes toward the THN 
distribution movement and laypersons’ capabilities to safely and successfully administer THN to 
overdose victims, most remained undecided on their intentions to prescribe THN. These findings 
suggested that positive attitudes do not necessarily predict that NPs will prescribe THN in their 
practices, which paralleled the findings of other studies (Leece et al., 2015; Wilson et al., 2016). 
This study also demonstrated that negative attitudes toward THN correlate significantly with 
unwillingness to prescribe THN to laypersons.  
In the survey’s comment section, NPs expressed concern that opioid abusers would feel 
false security if prescribed THN and subsequently engage in riskier opioid use. Throughout the 
literature, this THN ​safety net​ fear has contributed to negative attitudes among healthcare 
providers, law enforcement, paramedics, and the general public (Banta-Green, Beletsky, 
Schoeppe, Coffin, & Kuszler, 2013; Beletsky et al., 2007; Green et al., 2013; Kim et al., 2009; 
Leece et al., 2015). Despite this concern, evidence has consistently shown that laypersons do not 
participate in increased or riskier opioid use when given THN, and experts have explained that 
opioid-dependent persons typically avoid naloxone’s intensely unpleasant yet harmless opioid 
withdrawal symptoms (Kim et al., 2009). Other NPs voiced concern over risks of adverse 
reactions, such as seizures, arrhythmias, pulmonary edema, and the return of respiratory 
depression due to naloxone’s short half-life. However, a thorough literature review of naloxone’s 
pharmacological safety and efficacy concluded that serious adverse effects were rare and often 
caused by comorbidities, polysubstance use, or prolonged hypoxia, rather than the naloxone 
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itself (Wermeling, 2015). Evidence also suggested that repeat dosing of IN and injectable THN 
for recurring respiratory depression in pre-hospital overdose events was rare and more often 
occurred during inpatient IV naloxone reversals due to IV naloxone’s faster pharmacokinetics 
(Wermeling, 2015).  
Attitudes toward medicolegal implications also significantly correlated with NPs’ 
intentions to prescribe THN. When assessing NPs’ attitudes toward the medicolegal implications 
of writing THN prescriptions, overall responses were negative. Only 19.2% felt they were 
protected from criminal prosecution, while even less (15.7%) believed they were immune from 
civil liability if they prescribed THN to laypersons. Though these percentages of NPs were small, 
findings show that NPs with full understanding and confidence in their state’s naloxone 
legislation demonstrate more willingness to prescribe THN to laypersons. Most NPs neither 
agreed nor disagreed when asked if they felt legally protected to prescribe THN, which suggests 
that providers may be confused by, unaware of, or ambivalent toward naloxone laws. While 
many states, including Tennessee, have expanded legislation to ensure better provider protection, 
these findings add to evidence claiming that healthcare providers still feel that prescribing THN 
to laypersons could result in legal repercussions (Beletsky et al., 2007; Green et al., 2013; Leece 
et al., 2015). For example, one of the NPs practicing in a pain management clinic commented 
that although she felt prescribing THN was a good idea, she was afraid that writing THN 
prescriptions for her patients would send the message that she is prescribing inappropriate 
amounts of opioids. While perceptions of malpractice liability remain a barrier to providers 
prescribing THN, the true legal risk to providers has been low (Burris et al., 2009). Ultimately, 
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NPs and other providers will need clarification on medicolegal truths surrounding THN 
prescription.  
 
Subjective Norms  
Adding to this project’s findings on knowledge and attitudes, subjective norms were 
significantly associated with NPs intentions to prescribe THN. Healthcare providers’ reluctance 
to prescribe THN has often been attributed to lack of support from other providers and the 
medical community (Beletsky et al., 2007; Leece et al., 2015). However, this study found 71.1% 
of NPs indicated that peer pressure from other providers would not influence whether or not they 
decide to prescribe THN, and peer pressure was the only subjective norm that showed no 
significant correlation with prescribing intention. This finding could be because most NPs also 
believed that their provider peers were unaware of THN distribution, and they were uncertain of 
peer providers’ support for THN distribution. The stigma surrounding opioid abusers and addicts 
has also been a widely recognized barrier to provider prescription of THN, as providers may fear 
professional or social criticism when writing THN prescriptions for this population (Beletsky et 
al., 2007; Green at al., 2013; Leece et al., 2015). By introducing accurate and evidence-based 
information to providers and the general public, this stigma could be reversed.  
Intention to Prescribe, Prescribing Protocols and Appropriate Naloxone Recipients 
A mere 16.6% of NPs in this project intended to prescribe THN to laypersons, which was 
a much smaller percentage than the 46% of physicians polled in a study by Beletsky et al. 
(2007). This discrepancy may be attributable to the fact that this project’s sample had a much 
smaller percentage (16.3%) of NPs treating patients for pain management. Regardless, NPs’ 
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responses revealed a dramatic positive shift to 58% when asked if they would prescribe THN 
with prescribing protocols in place. This finding provides quantifiable support for the consistent 
recommendation that prescribing protocols and standard guidelines would increase healthcare 
providers’ prescribing practices (Green et al., 2013; Leece et al., 2015; Wermeling, 2015; Wilson 
et al., 2016). Protocols would ensure that providers uniformly write prescriptions in an 
evidence-based manner, which could reduce ambiguity and make providers feel more secure. 
Developed by an advocacy group of public health experts, physicians, pharmacists, and 
attorneys, prescribetoprevent.org provides current naloxone research, legal facts, and prescribing 
guidelines to healthcare providers so that they may make informed decisions when considering 
THN prescription (Prescribe to Prevent, 2015). Many NPs participating in this project expressed 
their desire for evidence, training, and prescribing guidelines to clarify confusion and enhance 
their confidence when prescribing THN. 
For providers who intend to prescribe THN, astute identification of THN candidates 
should be a priority. While this priority has been thoroughly discussed throughout the literature, 
there has been much debate over what defines a patient as “high-risk” and whether third-party 
prescription is appropriate (Beletsky et al., 2007; Green et al., 2013; Leece et al., 2015). In this 
project, NPs selected the following as the four most appropriate candidates for THN prescription: 
patients prescribed moderate to high doses of opioids for pain management, law enforcement, 
individuals addicted to oral opioids, and family and friends of patients taking prescribed opioids. 
Nurse practitioners’ candidate selections provided support for current efforts to dispense THN to 
individuals who would be the first to arrive at overdose events, such as police officers 
(Banta-Green et al., 2013). This project’s findings showed more support for THN prescription to 
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oral opioid users and their associates, which is significant because research has instead focused 
on THN distribution to IV drug users (Wheeler et al., 2015). To help providers identify 
appropriate THN candidates, Prescribe to Prevent (2015) offers standardized screening tools on 
its website. 
Limitations 
While this project produced significant findings, certain limitations must be considered. 
The investigator created the THNPS based on theoretical underpinnings and pertinent literature 
findings; however, the survey has not yet been formally validated. A validated survey instrument 
would have added further rigor to this study’s findings. In addition, the survey included a 
comments section in which NPs could provide additional thoughts and feelings if they so chose. 
It may have been useful to provide further opportunities for open-ended commentary with each 
quantitative question to better capture NPs’ knowledge, attitudes, subjective norms, and 
intentions. Furthermore, only family practice, adult primary, ED, and pain management NPs 
were included in the final sample. In hindsight, it may have been valuable to include the 
responses of all NPs, especially those practicing in mental health or substance abuse specialties 
because they regularly encounter patients with opioid abuse disorders.  
Lastly, the time period for data collection coincided with the CVS (2015) announcement 
that THN would be provided without individual prescription in Tennessee along with 12 other 
states. While this timing could not be helped, it is possible that NPs’ responses were impacted by 
the media coverage. Ultimately, THN distribution is an evolving movement with current efforts 
striving for pharmacy-dispensing models and over-the-counter availability. Both aforementioned 
strategies would reduce the urgency for provider prescription; however, it will always be 
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imperative for healthcare providers to be knowledgeable about THN, provide sufficient 
education for patients, and direct appropriate candidates to places where they can obtain THN. 
Furthermore, healthcare providers will likely still be needed for THN prescriptions to combat 
rising costs of naloxone and uncertain insurance coverage (Thompson, 2015). Regardless, some 
states still have not introduced or fully adopted strategies in which individuals can acquire THN 
without prescription, so healthcare providers currently remain the necessary link to THN access.  
Recommendations 
From this project’s findings, the investigator proposes specific recommendations for 
future research and NP practice. Nurse practitioners and other healthcare providers must be 
educated on the evidence surrounding THN safety and efficacy. Without knowledge of THN’s 
effectiveness in reducing opioid overdose deaths, NPs are less likely to prescribe it to their 
patients. Furthermore, THN advocates should increase specific messaging to healthcare 
providers and promote incentives for prescribing THN to change attitudes toward THN 
distribution. Medicolegal truths should be explained to NPs to increase confidence in their 
protection from malpractice liability when prescribing THN. Better education and training 
should be implemented among the entire medical community to deliver a clear and factual 
message regarding THN distribution to candidates so that providers will feel better support for 
prescribing THN. Nurse practitioners should be involved with developing and implementing 
THN prescribing protocols, identifying appropriate candidates, facilitating community outreach 
efforts, and initiating new research on THN’s effectiveness in practice. More data are needed to 
best execute THN distribution to oral opioid abusers or patients taking high doses of opioids for 
pain management. Therefore, NPs practicing in pain management specialties may be able to 
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provide this information. Ultimately, efforts should be made to incorporate THN distribution 
with other strategies to decrease opioid abuse, diversion, and overdose. More research is needed 
on THN effectiveness among individuals taking prescribed opioids for pain management.  
 
Conclusion 
While many factors contribute to NPs’ lack of involvement with THN distribution, 
knowledge, attitudes, and subjective norms remain influencing factors for intention to prescribe. 
This DNP project’s findings add breadth to the existing literature along with new information on 
NPs’ perceptions and willingness to prescribe. Better education, training, legal guidance, and 
support should be given to NPs to increase their confidence in THN prescription and distribution. 
Prescribing protocols should be developed to ensure safe and efficient THN prescription by NPs. 
To address this growing opioid overdose epidemic in Tennessee and across the U.S., it is 
imperative that NPs and other healthcare providers take this opportunity to advocate for patients 
at risk for opioid overdose, implement preventative efforts through safer opioid prescribing 
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2) Which answer best describes your knowledge about 
the following statements?  
  
In many states, healthcare providers may legally 
prescribe take-home naloxone to non-medically trained 
laypersons. After being trained on how to recognize 
signs of overdose and administer naloxone, these 
laypersons may legally administer naloxone to opioid 
overdose victims in a non-hospital setting. 
I have NEVER 
heard of this 
 
I have heard of 
this, but I am NOT 
SURE what it 
means 
  
I have heard of 
this, and I am 
SOMEWHAT 
SURE what it 
means 
 
I have heard of 
this, and I am 
VERY SURE what 
it means. 
 
3) Does Tennessee have a law that permits healthcare 
provider prescription of naloxone to laypersons for 
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4) Have you ever prescribed naloxone for a layperson to 







5) Select the answer that best describes your feelings 
toward the following statement.  
 
Prescribing take-home naloxone to laypersons is a good 













6) Select the answer that best describes your feelings 
toward the following statement.  
 
Laypersons receiving appropriate overdose response 
training can safely and successfully administer 












7) Select the answer that best describes your feelings 
toward the following statement.  
 
I am protected from criminal prosecution if I prescribe 












 8) Select the answer that best describes your feelings 
toward the following statement.  
 
I am protected from civil liability if I prescribe 





Neither agree nor 
disagree 
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9) Select the answer that best describes your feelings 
toward the following statement. 
 
Providers in my current practice site are aware of 












10) Select the answer that best describes your feelings 
toward the following statement. 
 
Providers in my current practice site support naloxone 












11) Select the answer that best describes your feelings 
toward the following statement.  
 
Peer pressure from other prescribers at my practice site 
will influence my decision to prescribe or not prescribe 












12) Select the answer that best describes your feelings 
toward the following statement.  
 
I have personal reasons that motivate my decision to 
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13) Do you intend to prescribe naloxone to laypersons 








14) If your practice site had a protocol to help guide 
provider prescription of take-home naloxone, would 
you prescribe naloxone to laypersons for use in 







15) Select all answers that apply (You may choose 
multiple answers).  
 
In your current practice, which individuals would you 
feel comfortable prescribing naloxone to? 
Patients taking low 
to moderate doses 
of opioid pain 




moderate to high 
doses of opioid 











Family members or 
friends of patients 
taking opioid pain 
medication 
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Family members or 
friends of IV 
























Table 2  
Demographic Characteristics of Participants 














Gender     0.456 
Male  33 (9.6)     8 (24.2)   10 (30.3)   15 (45.5)  
Female 310 
(90.4) 
  49 (15.8) 110 (35.5) 151 (48.7)  
Race/Ethnicity     0.799 
White 312 
(91.0) 
  51 (16.3) 111 (35.6) 150 (48.1)  
Black/African American   19 (5.5)     5 (26.3)     6 (31.6)     8 (42.1)  
Hispanic/Latino     4 (1.2)     0 (0.0)     1 (25.0)     3 (75.0)  
Asian     1 (0.3)     0 (0.0)     0 (0.0)     1 (100)  
American Indian/Alaskan 
Native 
    1 (0.3)     0 (0.0)     0 (0.0)     1 (100)  
Native Hawaiian/Other 
Pacific Islander 
    1 (0.3)     0 (0.0)     1 (100)     0 (0.0)  
Two or more races     2 (0.6)      0 (0.0)     0 (0.0)     2 (100)  
Declined to answer     3 (0.9)     1 (33.3)     1 (33.3)     1 (33.3)  
NP Years of Experience     0.070 
Less than 1     4 (1.2)     1 (25.0)     1 (25.0)     2 (50.0)  
1 to 2   50 
(14.6) 
    7 (14.0)   21 (42.0)   22 (44.0)  
3 to 4   49 
(14.3) 
  11 (22.5)   13 (26.5)   25 (51.0)  
5 to 6   55 
(16.0) 
    7 (12.7)   25 (45.5)   23 (41.8)  
7 to 8   32 (9.3)     1 (3.1)   16 (50.0)   15 (46.9)  
9 to 10   32 (9.3)     6 (18.7)   11 (34.4)   15 (46.9)  
11 to 12   17 (5.0)     3 (17.7)     9 (52.9)     5 (29.4)  
13 to 14   21 (6.1)     4 (19.1)     6 (28.6)   11 (52.4)  
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Note​. Rural and urban counties defined using the 2010 U.S. Census Office of Management and 
Budget (OMB) map of Tennessee counties.  
† = ​p ​< 0.05; ​φ​ = ​p​ < 0.01; * =​ p​ < 0.001 
Table 3 
 
Summary of Factors Influencing Nurse Practitioners’ Intentions to Prescribe Naloxone to 
Laypersons 
 
15 to 16   20 (5.8)     4 (20.0)     8 (40.0)     8 (40.0)  
17 to 18   18 (5.2)     5 (27.8)     0 (0.0)   13 (72.2)  
19 to 20   11 (3.2)     0 (0.0)     4 (36.4)   11 (63.6)  
More than 20   34 (9.9)     8 (23.5)     6 (17.7)   20 (58.8)  
Practice Site     0.000
* 
Adult primary care clinic   77 
(22.4) 
  10 (13.0)   26 (33.8)   41 (53.2)  
Family practice clinic 170 
(49.6) 
  19 
(11.2)​φ 
  69 (40.6)​†   82 (48.2)  
Pain management clinic   56 
(16.3) 
  25 
(44.6)* 
  10 (17.9)​φ   21 (37.5)  
Emergency department   40 
(11.7) 
    3 (7.5)   15 (37.5)   22 (55.0)  
Practice Location     0.629 
Rural   81 
(23.6) 
  11 (13.6)   26 (32.1)   44 (54.3)  
Urban 172 
(50.1) 
  33 (19.2)   61 (35.5)   78 (45.3)  
Combined rural and urban   90 
(26.2) 
  13 (14.4)   33 (36.7)   44 (48.9)  
  Intend to Prescribe Naloxone  













Aware of take-home naloxone 
distribution in the U.S. 
    0.000
* 
Very aware 158 
(46.1) 
  46 
(29.1)* 
  42 (26.6)​φ   70 (44.3)  
Somewhat aware   73 
(21.3) 





    4 (3.6)*   54 (48.2)*   54 (48.2)  
Knowledge of Tennessee’s 
naloxone distribution law 
    0.000
* 
Yes   65 
(19.0) 
  25 
(38.5)* 
  12 (18.5)​φ   28 (43.1)  
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No   65 
(19.0) 





  24 
(11.3)* 
  75 (35.2) 114 (53.5)†  
Previously prescribed take-home 
naloxone to laypersons 
    0.000
* 
Yes   17 (5.0)   16 
(94.1)* 





  41 
(12.6)* 
120 (36.8)​φ 165 (50.6)*  
Prescribing take-home naloxone is a 
good overdose prevention strategy 




  50 
(30.1)* 
  21 (12.7)*   95 (57.2)​φ  
Neither agree nor disagree 102 
(29.7) 
    4 (3.9)*   39 (38.2)   59 (57.8)†  
Disagree 
 
  75 
(21.9) 
    3 (4.0)*   60 (80.0)*   12 (16.0)*  
Laypersons can safely and 
successfully administer naloxone to 
overdose victims 




  54 
(22.5)* 
  51 (21.3)* 135 (56.3)*  
Neither agree nor disagree   62 
(18.1) 
    2 (3.2)​φ   36 (58.1)*   24 (38.7)  
Disagree 
 
  41 
(12.0) 
    1 (2.4)​φ   33 (80.5)*     7 (17.1)*  
Feel protected from criminal 
prosecution if prescribing 
take-home naloxone 
       0.000
* 
Agree   66 
(19.2) 
  29 
(43.9)* 
  13 (19.7)​φ   24 (36.4)†  
Neither agree nor disagree 157 
(45.8) 
  17 
(10.8)​φ 





  11 (9.2)​φ   57 (47.5)*   52 (43.3)  
Feel protected from civil liability if 
prescribing take-home naloxone 
    0.000
* 
Agree   54 
(15.7) 
  24 
(44.4)* 
    9 (16.7)​φ   21 (38.9)  
Neither agree nor disagree 157 
(45.8) 





  11 (8.3)​φ   65 (49.2)*   56 (42.4)  
Health provider peers are aware of 
take-home naloxone distribution 
        0.000
* 
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Agree   89 
(25.9) 
  28 
(31.5)* 
  27 (30.3)   34 (38.2)†  
Neither agree nor disagree 101 
(29.4) 





  14 (9.2)​φ   63 (41.4)†   75 (49.3)  
Health provider peers support 
take-home naloxone distribution 
    0.000
* 
Agree   49 
(14.3) 
  31 
(63.3)* 
    3 (6.1)*   15 (30.6)​φ  
Neither agree nor disagree 202 
(58.9) 
  21 
(10.4)* 
  59 (29.2)​φ 122 (60.4)*  
Disagree 
 
  91 
(26.5) 
    4 (4.4)*   58 (63.7)*   29 (31.9)*  
Peer pressure will influence 
decision to prescribe or not 
prescribe take-home naloxone 
    0.447 
Agree   43 
(12.5) 
    8 (18.6)   12 (27.9)   23 (53.5)  
Neither agree nor disagree   56 
(16.3) 





  38 (15.6)   93 (38.1) 113 (46.3)  
Have personal reasons that 
influence decision to prescribe or 
not prescribe take-home naloxone 
    0.015
† 
Agree   76 
(22.2) 
  15 (19.7)   33 (43.4)   28 (36.8)†  
Neither agree nor disagree   83 
(24.2) 





  35 (19.0)   52 (28.3)​φ   97 (52.7)  
Would prescribe take-home 
naloxone if prescribing protocol 
existed 




  57 
(28.6)* 
  27 (13.6)* 115 (57.8)*  
No   49 
(14.3) 
    0 (0.0)*   48 (98.0)*     1 (2.0)*  
Unsure   95 
(27.7) 
    0 (0.0)*   45 (47.4)​φ   50 (52.6)  
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